Professional Documents
Culture Documents
Makalah PA-A - Group 4 - PRODUCTION OF PLANT ANTIBODIES AS A PLANT PROTECTION PRODUCT
Makalah PA-A - Group 4 - PRODUCTION OF PLANT ANTIBODIES AS A PLANT PROTECTION PRODUCT
PRODUCT
Lecture : Dr. Ir. Rukmowati Brotodjojo, M. Agr.
Arranged by :
Group 4
134210057 Hesti Ruhaimah
134210058 Widya S. A. Pangaribuan
134210059 Sisilia Maharani
134210060 Firdaus
134210064 Regina Valeria Barus
PA-A Class
A. Background
Plant diseases are disorders or abnormalities that occur in plants
caused by various factors. Many factors that cause plant diseases are
caused by pathogens. Pathogens are living organisms, the majority of
which are microorganisms and are capable of causing disease in plants or
plants. Microorganisms include fungi, bacteria, viruses, mycoplasma
nematodes. There have been many efforts to control plant pest
organizations, one of which is to produce plant antibodies as plant
protection products using biotechnology.
Around 1990, plants were first considered as a potential host for
producing antibodies and the word “plantibody” was coined. The term
“plantibodies” describes the products of plants that have been genetically
engineered to express antibodies and antibody fragments. With this
technology, plants are being used as antibody factories (bioreactors),
utilizing their endomembrane and secretory systems to produce large
amounts of clinically viable proteins which can later be purified from the
plant tissue. Antibodies can be expressed in plants as either full-length
molecules or as smaller fragments. In essence, a plantibody is an antibody
produced by genetically modified plants. Antibodies, originally derived
from animals, are produced in plants by transforming the latter with
animal antibody genes. Although plants do not naturally make antibodies,
plantibodies have been shown to function in the same way as normal
antibodies. This concept of using plants as heterologous expression
systems for recombinant antibodies (plantibodies) is now more than two
decades old.
B. Research Problems
Based on the background that has been described above, the
problems that can occur are how are antibodies formed in plants for plant
protection against pathogens through biotechnology?
C. Objectives
The objective of this paper is Knowing the formation of antibodies
in plants for plant protection against pathogens through biotechnology.
CHAPTER II
DISCUSSION
A. Antibody Structure
Antibodies (abbreviated Ab), also known as immunoglobulins
(abbreviated Ig), are large, Y-shaped proteins used by the immune system
to identify and neutralize foreign objects such as pathogenic bacteria and
viruses. Antibodies recognize the pathogen's unique molecules, called
antigens. Each "Y" end of the antibody contains a paratope (analogous to a
lock) that is specific for one particular epitope (analogous to a key) on the
antigen, allowing these two structures to bond precisely. Using this
binding mechanism, antibodies can mark infected microorganisms or cells
for attack by other components of the immune system or can neutralize
them directly (e.g. by blocking parts of the virus that are important for
invasion).
Antibodies are glycoproteins that belong to the immunoglobulin
superfamily. The terms antibody and immunoglobulin are often used
interchangeably,[1] although the term 'antibody' is sometimes used for
both secreted and soluble forms, in other words, excluding B cell
receptors.[6] Antibodies play a role in the body's immunity as preventing
pathogens from entering or damaging cells by binding to them, stimulating
the destruction of pathogens by coating them by macrophages and other
cells; and trigger pathogen damage by stimulating other immune responses
such as the complement pathway.
In humans and most mammals, an antibody unit consists of four
polypeptide chains, namely two identical heavy chains and two identical
light chains; they are linked by disulfide bonds. Each chain is a series of
domains: somewhat similar sequences each consisting of about 110 amino
acids. This domain is usually represented in a simplified schematic as a
rectangle. The light chain consists of one VL variable domain and one CL
constant domain, while the heavy chain contains one VH variable domain
and three to four constant domains CH1, CH2, and so on.
Structurally, antibodies are also divided into two antigen-binding
fragments (Fab), each of which contains one VL, VH, CL, and CH1
domain, and a crystallizable fragment (Fc), which forms part of the stem
of the letter Y.[11] Between them there is a hinge region of the heavy
chain whose flexibility allows antibodies to bind epitope pairs at various
distances, to form molecular complexes (dimers, trimers, etc.), as well as
to bind effector molecules more easily.
2. Phage Display
Phage display was developed to mimic the key features of
antibody generation by the immune systems for isolating antibody
specificities. Recombinant DNA and molecular display
technologies have provided new opportunities for the creation of
recombinant antibodies. Phage display, involves the introduction of
peptide sequences (such as the antigen-binding domains of
recombinant antibodies) into the coat protein gene of a
bacteriophage so that multiple copies of the peptide are displayed
on the virion surface. Large peptide libraries, including diverse
libraries of antibodies, can be prepared using phage display and
screened by a process known as panning. Phage display can be
achieved using particles containing a whole phage genome plus the
inserted peptide. The phage particles may be used to transduce a
phagemid (a plasmid carrying the phage origin of replication and
one gene encoding a coat protein fusion). In the latter approach,
superinfection with a helper phage is necessary to package the
phagemid. This is preferable when the displayed protein is large
enough to reduce the infectivity of the phage particles, to avoid
packaging constraints. The minor coat protein pIII can tolerate N-
terminal fusions with scFvs, but larger peptides such as Fab
fragments are displayed more efficiently by fusion with the pVIII
major coat protein.
Phage display has been used by various plant virologists in
identification of peptides that bind to a pathogenic virus’s coat
protein. The phage display isolated peptides were very specific and
highly sensitive. At the very least, these have diagnostic potential
as they can be produced as fusions with proteins that serve as an
antigen for antibody-reporter molecule conjugates. They may also
constitute the basis for a novel, introduced disease resistance
strategy. Peptides with high affinity and specificity for vital viral
proteins could be identified, and subsequently, the capacity to
synthesize these peptides may be introduced into plants.
In planta peptide production might prevent viral
proliferation in infected cells. Such a strategy has been used
successfully with antibodies, but antibody folding usually requires
an oxidizing environment conducive to forming specific
intracellular disulfide bonds necessary for function. Phage display-
selected peptides may not be so exacting in their requirements.
Indeed, phage display selected peptides capable of binding to a
coat protein of the rice black streaked dwarf virus (RBSDV), when
produced recombinantly for diagnostic purposes, have been shown
to also disrupt proper coat protein folding and reduce the
pathogenicity of RBSDV. Phage display has also assisted in the
elucidation of various host systems secunded to the virus to permit
successful infection and replication. Using the viral replication
enhancer protein, AC3 as bait, a phage library of random
dodecapeptides fused to a coat protein was panned to identify
interacting peptides that were then analyzed for homology to
proteins from the model plant, Arabidopsis thaliana. The revelation
of the pathways to which these proteins are integral has allowed a
more sophisticated understanding of events required for successful
viral lifecycle and the role of the multifunctional protein AC3 in
events leading to virus-induced gene silencing (Kushwaha et al.,
2012).
Numerous cloning and mutagenesis strategies have been
developed to create. preserve, and exploit maximal antibody
diversity. As in the immune system, isolated scFv genes can be
subjected further to mutation, and the mutants with more desirable
characteristics then can be selected. Phage display antibodies can
be used in the same range of applications as their hybridoma
counterparts, and moreover, can offer several advantages over
hybridoma methods. Phage antibody generation is rapid and can be
prepared in a few weeks using microgram levels of antigen. Phage
display can produce antibodies that are not readily prepared by
hybridoma technology. These scFv antibodies can be manipulated
genetically with ease for the construction and expression of new
recombinant proteins, such as AFP-scFv fusions described below.
In addition, phage display hasbeen used also for the selection of
other proteins with binding properties (Simon et al., 2004).